Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

TLX SP ?3.75 RT, SLActive? 10mm, RXD: medical device reports filed with FDA

822 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

822
device reports naming the brand
0% of all MAUDE reports · about 154 a year
195
reports, 12 months to August 2026
190 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

822 medical device reports received by FDA name the brand "TLX SP ?3.75 RT, SLActive? 10mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from March 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

195 reports arrived in the 12 months to August 2026, close to the 190 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (75.4%), loss of osseointegration (16.4%) and difficult to insert (0.5%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01632Sep 2021: 1Oct 2021: 0Nov 2021: 2Dec 2021: 02022Jan 2022: 3Feb 2022: 4Mar 2022: 5Apr 2022: 8May 2022: 8Jun 2022: 6Jul 2022: 14Aug 2022: 10Sep 2022: 4Oct 2022: 16Nov 2022: 8Dec 2022: 132023Jan 2023: 12Feb 2023: 14Mar 2023: 6Apr 2023: 6May 2023: 11Jun 2023: 15Jul 2023: 16Aug 2023: 21Sep 2023: 26Oct 2023: 19Nov 2023: 24Dec 2023: 232024Jan 2024: 11Feb 2024: 24Mar 2024: 18Apr 2024: 21May 2024: 16Jun 2024: 10Jul 2024: 15Aug 2024: 22Sep 2024: 10Oct 2024: 10Nov 2024: 19Dec 2024: 242025Jan 2025: 17Feb 2025: 10Mar 2025: 18Apr 2025: 12May 2025: 0Jun 2025: 32Jul 2025: 19Aug 2025: 19Sep 2025: 6Oct 2025: 17Nov 2025: 15Dec 2025: 172026Jan 2026: 11Feb 2026: 16Mar 2026: 13Apr 2026: 14May 2026: 28Jun 2026: 16Jul 2026: 24Aug 2026: 18

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01002002021: 820212022: 9920222023: 19320232024: 20020242025: 18220252026: 1402026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%822
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report93.9%772
Voluntary report0%0
User facility report0%0
Distributor report6.1%50
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate62075.4%62.8%
Loss of osseointegration13516.4%22.4%
Difficult to insertthe device was hard to insert40.5%0.4%
Fracturea broken bone10.1%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis30437%
Painpain, site not specified16219.7%
Inflammationinflammation364.4%
Hemorrhage/blood loss/bleeding344.1%
Swelling/ edema344.1%
Hyperresponsive to stimuli111.3%
Fistula101.2%
Abscessa collection of pus70.9%
Hypersensitivity/allergic reaction70.9%
Numbnessnumbness50.6%
Sinus perforation30.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTLX SP ?3.75 RT, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports8223,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer93.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about TLX SP ?3.75 RT, SLActive? 10mm, RXD reports

How many FDA reports name TLX SP ?3.75 RT, SLActive? 10mm, RXD?

822 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 195 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (75.4%), loss of osseointegration (16.4%), difficult to insert (0.5%) and fracture (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (93.9%) and distributor reports (6.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that TLX SP ?3.75 RT, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.